Alembic Pharmaceuticals on Monday, May 6, announced that it has received an establishment inspection report (EIR) from the…
Aarti Drugs said in an exchange filing that the company has received five observations in Form 483 from the United State…
"Because your drug products were prepared, packed, or held under insanitary conditions, whereby they may have become …
The death toll in the blast at the chemical manufacturing unit in Telangana's Sangareddy district rose to six on Thurs…
The United States Food & Drug Administration (USFDA) has issued a form 483 with six inspectional observations to Cipla…
Alembic Pharmaceuticals on Wednesday said flash floods in the Teesta River has led to disruption in operations at its Sikki…
Alembic Pharmaceuticals Limited (Alembic) today announced that its wholly owned subsidiary, Aleor Dermaceuticals Limited (Al…
Novo Nordisk will be sharing its new data in the treatment of rare diseases which will be revealed at the International So…
YOU ARE PHARMAVIEWS.NET US biomedical giant Moderna has announced plans to build a £1bn state-of-the-art research and m…
Hyderabad-based conglomerate INCOR Group and Renovis Labs , have entered into a new JV ‘INCOR Renovis’. The new company wi…
Drug-maker Aurobindo Pharma on June 27 informed the stock exchanges that it has received a "warning letter" …
In the pharmaceutical industry, AstraZeneca Pharma India Ltd. is a mid-cap company with a market cap of Rs. 6,822 crore. W…
Strides Pharma announced on June 24 results from a Phase II/III clinical trial in India of the SARS-CoV-2 vaccine, AKS-452,…
Our website uses cookies to improve your experience. Learn more
Ok